⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCS News
Oculis Holding AG Ordinary shares
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
globenewswire.com
OCS
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
globenewswire.com
OCS
Oculis Publishes Invitation to the Annual General Meeting
globenewswire.com
OCS
Oculis Publishes Invitation to the Annual General Meeting
globenewswire.com
OCS
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
globenewswire.com
OCS
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
globenewswire.com
OCS
Oculis to Participate in Upcoming Investor Conferences
globenewswire.com
OCS
Oculis to Participate in Upcoming Investor Conferences
globenewswire.com
OCS
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
globenewswire.com
OCS
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
globenewswire.com
OCS